Trilostane
(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile
Molecular Identity
Trilostane
(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile
PubChem CID: 656583
Trilostane can cause developmental toxicity according to state or federal government labeling requirements.
2D Structure
Properties
C20H27NO3
Molecular Formula
329.40
Molecular Weight
g/mol
329.1991
Exact Mass
Da
2.9
XLogP
Drug-like (Lipinski: < 5)
76.8
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
4
H-Bond Acceptors
692
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Trilostane13647-35-3ModrenalVetorylDesopanModrastaneTrilostanoWin-24540TrilostanumWIN 24,540DTXSID9023706L0FPV48Q5RAndrost-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4alpha,5alpha,17beta)-Win 24540CHEBI:32260
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Trilostane
Loading drug network...